RNA Therapeutics Advance Editing and Amplification at 2026 J.P. Morgan Conference
At the 2026 J.P. Morgan Healthcare Conference, RNA therapeutics re-emerged as a pivotal force in genetic medicine, evolving from mere gene silencers to versatile tools for editing, repairing, and